Levoflox

Levofloxacin, the active ingredient in Levoflox, is a fluoroquinolone presented as an intravenous solution for parenteral use. It treats a range of bacterial infections, including community‑acquired pneumonia, complicated urinary tract infections, skin and soft‑tissue infections, acute bacterial sinusitis, and acute exacerbations of chronic bronchitis in adult patients.

GNH USA supplies Levoflox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to European Union quality standards and provides reliable global distribution.

Levoflox, a fluoroquinolone antibacterial, is indicated for several serious bacterial infections.

- Community‑acquired pneumonia: eradicates the causative pathogens to improve respiratory function. - Complicated urinary tract infections: eliminates resistant bacteria to resolve infection and prevent renal complications. - Skin and soft‑tissue infections: clears bacterial load to promote wound healing. - Acute bacterial sinusitis: reduces sinus inflammation by targeting the infecting organisms. - Acute exacerbations of chronic bronchitis: controls bacterial overgrowth to improve airflow and reduce symptom severity.

Levoflox may cause a range of adverse reactions, which are classified by frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, sometimes watery. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness or imbalance.

Serious or Rare Side Effects: - Tendon rupture: sudden pain and loss of function, especially in the Achilles tendon. - QT interval prolongation: may lead to cardiac arrhythmias. - Clostridioides difficile infection: severe colitis presenting with watery diarrhea and abdominal pain.

Before initiating Levoflox therapy, clinicians should consider several safety precautions.

- Renal impairment: adjust dosing or monitor renal function closely. - History of tendon disorders: avoid use due to increased risk of tendon rupture. - QT prolongation risk: obtain baseline ECG and avoid concomitant QT‑prolonging drugs. - Pregnancy Category C: weigh maternal benefits against potential fetal risks. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Levoflox can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Antacids or supplements containing aluminum, magnesium, calcium, or iron: reduce levofloxacin absorption. - Warfarin: may increase anticoagulant effect and bleeding risk. - Systemic corticosteroids: heightened risk of tendon rupture. - Theophylline: increased plasma concentrations leading to toxicity.

Moderate Interactions (Monitor Closely): - Oral hypoglycemic agents: may cause abnormal blood glucose levels. - Digoxin: potential for increased serum digoxin concentrations. - Cyclosporine: may raise cyclosporine levels, requiring dose adjustment.